Home › NDC Lookup › Ingredients › Dextromethorphan Hbr Guaifenesin › 70677-1261-02
🧴image loading
(from DailyMed)

Tussin DM Dextromethorphan HBr Guaifenesin 20 mg/20mL; 200 mg/20mL Solution — NDC 70677-1261-2 (Billing 70677-1261-02)

by Strategic Sourcing Services LLC · 1 BOTTLE, PLASTIC in 1 CARTON / 237 mL in 1 BOTTLE, PLASTIC

This is a package of Tussin DM Dextromethorphan HBr Guaifenesin 20 mg/20mL; 200 mg/20mL Solution from Strategic Sourcing Services LLC, marketed since Feb 2025 and currently FDA-listed; retail pharmacies pay about $0.0148 per mL (NADAC).

NDC 70677-1261-02
🏷️ FDA NDC (as labeled) 70677-1261-2 billing pads the package segment with a zero
This package
Contains237 mL in 1 bottle, plastic Cost per mL$0.0148 NADAC Per package$3.51 / 237 ml Pack sizes2 compare ↓
Also priced by: Medicaid pays $0.0660/unit — full pricing hub ↓
Product page 70677-1261-01 Also comes in: 118 mL 70677-1261-1
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Oct 1, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 70677-1261-2
Product NDC 70677-1261
11-digit billing NDC 70677126102
NCPDP billing unit ML — per mL (volume)
RxCUI 1790650
UNII 9D2RTI9KYH, 495W7451VQ
UPC 0010939960764
Application # M012
SPL Set ID 84750bfb-9e94-40a3-b731-21799f5e4fd1
Established class (EPC) Expectorant
Physiologic effect Decreased Respiratory Secretion Viscosity; Increased Respiratory Secretions
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2025-02-26
Route ORAL
Dosage form SOLUTION
Substance DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GPI-14 43997002520924
GCN Seq No 079414
GCN 45903
HICL code 000223
Ingredient (HICL) Guaifenesin/Dextromethorphan
HIC1 code B
Therapeutic class — broad (HIC1) Respiratory System
HIC2 code B3
Therapeutic class — intermediate (HIC2) Drugs Affecting Primarily The Trachea And Bronchi
HIC3 code B3T
Therapeutic class — specific (HIC3) Non-Opioid Antitussive And Expectorant Combination
AHFS code 48:08.00.00
AHFS class Antitussives
FDB label name FT TUSSIN DM 200-20 MG/20 ML
FDB brand name Tussin Dm
Legend status O — Over-the-counter (OTC) drug or device
Quick answers
  • GSN (GCN sequence number): 079414
  • GCN: 45903
  • GPI-14 (Medi-Span): 43997002520924
  • HICL (First Databank): 000223
  • AHFS class code: 48:08.00.00
  • RxCUI (RxNorm): 1790650
Why two NDCs? The FDA registers this code as 70677-1261-2 — a 5-4-1 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the package segment → 70677-1261-02. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Uncompetitive N-methyl-D-aspartate Receptor Antagonist class.

Pharmacologic class Uncompetitive N-methyl-D-aspartate Receptor Antagonist, Sigma-1 Agonist
Drug family (ATC) Other antidepressants, Opium alkaloids and derivatives
How it works Uncompetitive NMDA Receptor Antagonists, Sigma-1 Receptor Agonists
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

Label name FT TUSSIN DM 200-20 MG/20 ML Ingredient Guaifenesin/Dextromethorphan
📗 Our plain-language guide HelloPharmacist
  • It helps loosen mucus and makes coughs more productive. It also temporarily eases cough from minor throat and bronchial irritation, like with a cold or inhaled irritants.
  • Swallow them whole with a full glass of water. Don’t crush, chew or break them. You can take them with or without food, about every 12 hours as your label directs.
  • How do I take the extended-release tablets?
  • The extended-release tablets are not for children under 12. Some liquid products are made for children, so check that product’s label and ask me if you’re unsure.
📖 Read our full Dextromethorphan / Guaifenesin guide →

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer mLPer package
Retail pharmacies payNADAC · weekly $0.015 $3.51 / 237 ml
Medicaid paysCMS SDUD · 12 mo $0.0660 $15.64 / 237 ml
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
NADAC price history (per mL) — tap or hover for the price & month
Dec 2025 Mar 2026 Jun 2026 Sep 2026 $0.016 $0.014
▲ Up 2% over the last 10 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Per unit Per pack Marketing startMarketing endStatus
70677-1261-01 70677-1261-1 Main listing 1 BOTTLE, PLASTIC in 1 CARTON / 118 mL in 1 BOTTLE, PLASTIC $0.0207 / mL $2.44 2025-02-26 — Active
70677-1261-02 You're viewing this 1 BOTTLE, PLASTIC in 1 CARTON / 237 mL in 1 BOTTLE, PLASTIC $0.0148 / mL $3.50 2025-02-26 — Active

This pack has the lowest per-mL cost of the 2 priced pack sizes ($0.0148 NADAC).

In Medicaid, this is the most-dispensed pack of this product — about 62% of fills over the last four reported quarters. See all packs ↓

Pack size FAQ

What quantity is in this package?
This package is listed by the FDA — 1 bottle, plastic in 1 carton / 237 ml in 1 bottle, plastic.
What NDC number is used to bill for this package of Tussin DM Dextromethorphan HBr Guaifenesin 20 mg/20mL; 200 mg/20mL Solution?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Prices are the latest CMS NADAC pharmacy acquisition cost per NDC; per-pack figures are per-unit × pack quantity, shown only when the pack is denominated in the same measure NADAC prices.

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Good Neighbor Dye Free Adult Tussin DM Cough and Chest Congestion 20 mg/20mL; 200 mg/20mL 46122-0783-34 AMERISOURCE 1 bottle $0.015 — Availability likely —
Tussin DM 20 mg/20mL; 200 mg/20mLthis 70677-1261-02 Strategic 1 bottle $0.015 — Availability likely —
rugby cough syrup 20 mg/20mL; 200 mg/20mL 00536-1348-97 Rugby 1 bottle $0.017 — Availability likely +14%
Tussin DM 200 mg/20mL; 20 mg/20mL 70677-1185-01 Strategic 1 bottle $0.020 — Availability likely +37%
good sense tussin dm 20 mg/20mL; 200 mg/20mL 00113-1725-26 L. 1 bottle $0.021 — Availability likely +40%
robafen dm 20 mg/20mL; 200 mg/20mL 00904-7223-20 Major 1 bottle $0.021 — Availability likely +40%
Robafen DM Cough 20 mg/20mL; 200 mg/20mL 00904-7441-20 Major 1 bottle $0.021 — Availability likely +40%
good neighbor pharmacy adult tussin DM 20 mg/20mL; 200 mg/20mL 46122-0704-26 Amerisource 1 bottle $0.021 — Availability likely +40%
Good Neighbor Sugar Free Adult Tussin DM Cough and Chest Congestion 20 mg/20mL; 200 mg/20mL 46122-0782-29 AMERISOURCE 1 bottle $0.021 — Availability likely +40%
Tussin DM 20 mg/20mL; 200 mg/20mL 70000-0670-01 Cardinal 1 bottle $0.021 — Availability likely +40%
foster and thrive adult tussin dm 20 mg/20mL; 200 mg/20mL 70677-1035-01 Strategic 1 bottle $0.021 — Availability likely +40%
QCH Adult Tussin DM 542 20 mg/20mL; 200 mg/20mL 83324-0023-04 Chain 1 bottle $0.021 — Availability likely +40%
QCH Adult Tussin DM Sugar free 545 20 mg/20mL; 200 mg/20mL 83324-0025-04 Chain 1 bottle $0.021 — Availability likely +40%
Childrens Robitussin Cough and Chest Congestion DM 20 mg/20mL; 200 mg/20mL 00031-8702-13 Haleon 1 bottle — — FDA listed —
Robitussin Cough Plus Chest Congestion Dm 20 mg/20mL; 200 mg/20mL 00031-8757-12 Haleon 1 bottle — — FDA listed —
Robitussin Sugar-Free Dye-Free Cough Plus Chest Congestion DM 20 mg/20mL; 200 mg/20mL 00031-8759-12 Haleon 1 bottle — — FDA listed —
Childrens Robitussin Honey Cough and Chest Congestion DM 10 mg/10mL; 100 mg/10mL 00031-8760-12 Haleon 1 bottle — — FDA listed —
adult tussin dm 20 mg/20mL; 200 mg/20mL 00363-1603-26 Walgreen 1 bottle — — FDA listed —
Walgreen Adult Cough Plus Chest Congestion Dm 20 mg/20mL; 200 mg/20mL 00363-7440-08 WALGREEN 1 bottle — — FDA listed —
Walgreens Grape Flavor 20 mg/20mL; 200 mg/20mL 00363-7470-04 WALGREENS 1 bottle — — FDA listed —
tussin cough and chest congestion 20 mg/20mL; 200 mg/20mL 11822-1630-00 Rite 1 bottle — — FDA listed —
equaline adult tussin 20 mg/20mL; 200 mg/20mL 41163-0813-26 United 1 bottle — — FDA listed —
Robafen Dm 20 mg/20mL; 200 mg/20mL 50090-6747-00 A-S 1 bottle — — FDA listed —
good sense tussin dm 20 mg/20mL; 200 mg/20mL 50090-7257-00 A-S 1 bottle — — FDA listed —
Cough And Chest Congestion 20 mg/20mL; 200 mg/20mL 51316-0082-34 CVS 1 bottle — — FDA listed —
Cough And Chest Congestion Dm 20 mg/20mL; 200 mg/20mL 51316-0473-34 CVS 1 bottle — — FDA listed —
Cvs Adult Cough Plus Chest Congestion Dm 20 mg/20mL; 200 mg/20mL 51316-0744-08 CVS 1 bottle — — FDA listed —
dg health adult tussin 20 mg/20mL; 200 mg/20mL 55910-0776-26 Dolgencorp 1 bottle — — FDA listed —
adult tussin dm 20 mg/20mL; 200 mg/20mL 56062-0607-26 Publix 1 bottle — — FDA listed —
tussin 20 mg/20mL; 200 mg/20mL 59640-0100-26 H 1 bottle — — FDA listed —
Premier Value 20 mg/20mL; 200 mg/20mL 68016-0744-04 PHARMACY 1 bottle — — FDA listed —
DRx Choice Children daytime Cough and Chest Congestion 20 mg/20mL; 200 mg/20mL 68163-0747-04 RARITAN 1 bottle — — FDA listed —
robafen dm 20 mg/20mL; 200 mg/20mL 68788-8268-01 Preferred 1 bottle — — FDA listed —
good sense tussin dm 20 mg/20mL; 200 mg/20mL 68788-8300-01 Preferred 1 bottle — — FDA listed —
rugby cough syrup 20 mg/20mL; 200 mg/20mL 68788-8303-01 Preferred 1 bottle — — FDA listed —
adult tussin dm 20 mg/20mL; 200 mg/20mL 69842-0513-26 CVS 1 bottle — — FDA listed —
leader tussin dm 20 mg/20mL; 200 mg/20mL 70000-0596-01 Cardinal 1 bottle — — FDA listed —
Tussin DM Cough plus Chest Congestion 20 mg/20mL; 200 mg/20mL 70000-0713-01 Cardinal 1 bottle — — FDA listed —
basic care tussin dm 20 mg/20mL; 200 mg/20mL 72288-0631-26 Amazon.com 1 bottle — — FDA listed —
careone tussin dm 20 mg/20mL; 200 mg/20mL 72476-0630-26 Retail 1 bottle — — FDA listed —
topcare tussin dm 20 mg/20mL; 200 mg/20mL 76162-0600-26 Topco 1 bottle — — FDA listed —
adult cough and chest congestion 20 mg/20mL; 200 mg/20mL 79481-0063-00 Meijer, 1 bottle — — FDA listed —
Meijer Children Cough and Chest Congestion DM Grape Flavor 20 mg/20mL; 200 mg/20mL 79481-7470-08 MEIJER 1 bottle — — FDA listed —
equate adult cough and chest congestion dm 20 mg/20mL; 200 mg/20mL 79903-0095-08 WALMART 1 bottle — — FDA listed —
Tussin DM 20 mg/20mL; 200 mg/20mL 83324-0327-04 Chain 1 bottle — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2025
On the market since
Feb 2025
📍
2026
Currently FDA-listed
1 year listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerStrategic Sourcing Services LLC
FDA applicationM012 (OTC MONOGRAPH DRUG)
Labeler code70677
First marketedFeb 2025
Product typeHuman Otc Drug
Portfolio316 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 📦 Storage and Handling 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 Do Not Use 📄 Ask a Doctor Before Use If 📄 Stop Use and Ask a Doctor If 🤰 If Pregnant or Breast-Feeding 📄 Keep Out of Reach of Children 📄 Questions or Comments 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 29 words ▾

Uses temporarily relieves cough due to minor throat and bronchial irritation as may occur with a cold helps loosen phlegm (mucus) and thin bronchial secretions to drain bronchial tubes

⏱️ Dosage and Administration 46 words ▾

Directions do not take more than directed do not take more than 6 doses in any 24-hour period mL = milliliter only use the dose cup provided adults and children 12 years and over: 20 mL every 4 hours children under 12 years: do not use

⚠️ Warnings 151 words ▾

Warnings Do not use if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions, or Parkinson’s disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product. Ask a doctor before use if you have cough that occurs with too much phlegm (mucus) persistent or chronic cough such as occurs with smoking, asthma, chronic bronchitis, or emphysema Stop use and ask a doctor if cough persists more than 7 days, tends to recur, or is accompanied by a fever, rash, or persistent headache.

These could be signs of a serious condition. If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children.

In case of overdose, get medical help or contact a Poison Control Center right away.

📦 Storage and Handling 27 words ▾

Other information each 20 mL contains: sodium 8 mg store at 25°C (77°F); excursions permitted between 15°-30°C (59°-86°F) see end flap for expiration date and lot number

🧪 Active Ingredient 13 words ▾

Active ingredients (in each 20 mL) Dextromethorphan HBr 20 mg Guaifenesin 200 mg

🧪 Inactive Ingredients 21 words ▾

Inactive ingredients anhydrous citric acid, flavors, glycerin, polyethylene glycol, propylene glycol, purified water, sodium benzoate, sodium citrate dihydrate, sucralose, xanthan gum

🎯 Purpose 4 words ▾

Purpose Cough suppressant Expectorant

📄 Do Not Use 55 words ▾

Do not use if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions, or Parkinson’s disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product.

📄 Ask a Doctor Before Use If 30 words ▾

Ask a doctor before use if you have cough that occurs with too much phlegm (mucus) persistent or chronic cough such as occurs with smoking, asthma, chronic bronchitis, or emphysema

📄 Stop Use and Ask a Doctor If 34 words ▾

Stop use and ask a doctor if cough persists more than 7 days, tends to recur, or is accompanied by a fever, rash, or persistent headache. These could be signs of a serious condition.

🤰 If Pregnant or Breast-Feeding 10 words ▾

If pregnant or breast-feeding, ask a health professional before use.

📄 Keep Out of Reach of Children 21 words ▾

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

📄 Questions or Comments 12 words ▾

Questions or comments? Call 833-358-6431 Monday to Friday 9:00am to 7:00pm EST

📄 Package Label / Principal Display Panel 130 words ▾

Principal display panel NDC 70677-1261-1 *COMPARE TO THE ACTIVE INGREDIENTS IN ROBITUSSIN® SUGAR-FREE DYE-FREE COUGH+CHEST CONGESTION DM Foster & Thrive ™ Tussin DM Dextromethorphan HBr Guaifenesin COUGH SUPPRESSANT EXPECTORANT Ages 12 Years and Over Oral Solution Sugar Free Dye Free Cool Mint Flavored • Controls Cough • Relieves Chest Congestion • Thins & Loosens Mucus DOSING CUP INCLUDED 4 FL OZ (118 mL) TAMPER EVIDENT: DO NOT USE IF PRINTED NECK WRAP IS BROKEN OR MISSING *This product is not manufactured or distributed by Haleon US Holdings LLC, owner of the registered trademark Robitussin® Sugar-Free Dye-Free Cough+Chest Congestion DM.

50844 ORG062307336 Rev. 12/24 ©2023 McKesson Corporation Distributed by: McKesson Corp., via Strategic Sourcing Services LLC., Memphis, TN 38141 Money Back Guarantee www.fosterandthrive.com Foster and Thrive 44-073 Foster and Thrive 44-073

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Medicaid utilization & spend

📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for this package alone, not the drug overall. Other pack sizes report separately.
💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.
📅 Q3 2025 – Q1 2026 · 3 quarters of data
ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.
Prescriptions last 4 qtrs
73
Units reimbursed last 4 qtrs
17K
Gross reimbursed last 4 qtrs
$1.1K
Avg / prescription
$15.40
Avg / unit
$0.0660
Latest quarter Q1 2026
73Rx
Medicaid pays / mL
$0.0660
gross reimbursed
vs
NADAC / mL
$0.0148
acquisition cost
=
Spread
+$0.0512
+346% vs cost
What Medicaid paid per mL (before rebates; includes the pharmacy’s dispensing fee) compared with NADAC — the average price pharmacies pay to buy the drug. A positive spread means Medicaid reimbursed more than the purchase price, before manufacturer rebates.
Fee-for-service vs managed care ⓘ
100% FFS
Fee-for-service · 73 Rx Managed care · 0 Rx
State Medicaid map
Alaska: no data reported AK Maine: no data reported ME Washington: no data reported WA Idaho: no data reported ID Montana: no data reported MT North Dakota: no data reported ND Minnesota: no data reported MN Wisconsin: no data reported WI Michigan: no data reported MI New York: no data reported NY Vermont: no data reported VT New Hampshire: no data reported NH Oregon: no data reported OR Nevada: no data reported NV Wyoming: no data reported WY South Dakota: no data reported SD Iowa: no data reported IA Illinois: no data reported IL Indiana: no data reported IN Ohio: no data reported OH Pennsylvania: no data reported PA New Jersey: no data reported NJ Massachusetts: no data reported MA California: 17,027 units · 43.7 per 100k residents CA Utah: no data reported UT Colorado: no data reported CO Nebraska: no data reported NE Missouri: no data reported MO Kentucky: no data reported KY West Virginia: no data reported WV Virginia: no data reported VA Maryland: no data reported MD Connecticut: no data reported CT Rhode Island: no data reported RI Arizona: no data reported AZ New Mexico: no data reported NM Kansas: no data reported KS Arkansas: no data reported AR Tennessee: no data reported TN North Carolina: no data reported NC South Carolina: no data reported SC Delaware: no data reported DE Oklahoma: no data reported OK Louisiana: no data reported LA Mississippi: no data reported MS Alabama: no data reported AL Georgia: no data reported GA D.C.: no data reported DC Hawaii: no data reported HI Texas: no data reported TX Florida: no data reported FL
Units reimbursed · per 100k residents
43.743.7
gray = no data reported ⓘ
Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.
Tap or hover a state
…for its Medicaid breakdown
🏆 Top states by units · per 100k residents
1 California 43.7 /100k
National units — by quarter
💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.

Medicaid utilization by pack size

Medicaid (SDUD) totals over the four most recent reported quarters for every package size of this drug — handy when a specific package (e.g. a starter/titration pack) carries little or no Medicaid volume on its own.
1 bottle this page70677-1261-02 73 Rx · $1,124
1 bottle70677-1261-01 44 Rx · $689
Drug total (last 4 qtrs): 117 Rx · 24,739 units · $1,813 gross reimbursed
Tap a pack size to open its page. Source: CMS State Drug Utilization Data, last 4 quarters.
← 70677-1260-01 · Strategic 70677-1262-01 · STRATEGIC →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.